Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.
Not yet recruitingOBSERVATIONAL
Enrollment
225
Participants
Timeline
Start Date
June 15, 2025
Primary Completion Date
June 14, 2029
Study Completion Date
June 14, 2029
Conditions
Congenital Heart SurgeryCongenital Heart Disease in ChildrenFontan Physiology
Trial Locations (1)
8008
University Children's Hospital Zurirch, Zurich
All Listed Sponsors
collaborator
University Children's Hospital, Zurich
OTHER
lead
Martin Schweiger
OTHER
NCT07029230 - Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure. | Biotech Hunter | Biotech Hunter